Do peptides help with visceral fat or just weight loss
18 Suppl 1:S12-6
But inflammation stems from numerous possible causes, not all of which are under your control
While the clinical impact of GLP-1s on approved indications (e.g., obesity, diabetes, cardiovascular risk) and adjacent indications is being studied extensively in clinical trials, there is limited scientific literature on GLP-1 use, efficacy or persistence outside of clinical trial settings
Read on to find out why this supplement has suddenly found its way into the spotlight, especially for women in midlife
The approval is supported by the OASIS clinical trial programme, where participants achieved around 17% average weight loss, with nearly one in three losing 20% or more, alongside lifestyle intervention